Cargando…
Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
Autores principales: | Lallana, Sofia, Siegler, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363468/ https://www.ncbi.nlm.nih.gov/pubmed/34509250 http://dx.doi.org/10.1016/j.jocn.2021.08.006 |
Ejemplares similares
-
Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19
por: Lallana, Sofía, et al.
Publicado: (2021) -
Correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
por: Sun, Dongren, et al.
Publicado: (2021) -
Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017) -
Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020) -
Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Bitar De Zayas-Enriquez, A., et al.
Publicado: (2019)